The Food and Drug Administration has approved the approval of Qutenza (capsaicin) 8% patch, a medicated skin patch that relieves the pain of post-herpetic neuralgia, a serious complication that can occur after a bout with shingles.
18 November, 2009
Germany's Paul-Ehrlich-Institute approves clinical trial in rheumatoid arthritis patients.
09 November, 2009
This will be the first evaluation of CureVac's RNActive® vaccine technology in humans.
05 November, 2009